Literature DB >> 23372865

Multisystemic Langerhans cell histiocytosis with advanced lung involvement.

Ricardo Andrade Fernandes de Mello1, Joana Waked Tanos, Melissa Bozzi Nonato Mello, Edson Marchiori.   

Abstract

Langerhans cell histiocytosis is a rare disease of unknown cause, characterized by the proliferation of histiocytic cells (Langerhans cells), that can sometimes be especially difficult to diagnose due to its wide clinical spectrum, ranging from a single lesion to a multisystemic disorder. Appropriate disease staging is fundamental, since treatment depends upon the severity of the disease, and imaging methods play a fundamental role not only in diagnosing and assessing the extent of Langerhans cell histiocytosis, as well as guiding the appropriate treatment for the patient and their monitoring.

Entities:  

Keywords:  Langerhans cell histiocytosis; computed tomography; lung; skin diseases

Mesh:

Year:  2012        PMID: 23372865      PMCID: PMC3558261          DOI: 10.3941/jrcr.v6i11.1130

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  10 in total

Review 1.  From the archives of the AFIP: pulmonary Langerhans cell histiocytosis.

Authors:  Gerald F Abbott; Melissa L Rosado-de-Christenson; Teri J Franks; Aletta Ann Frazier; Jeffrey R Galvin
Journal:  Radiographics       Date:  2004 May-Jun       Impact factor: 5.333

2.  Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.

Authors:  R M Egeler; B E Favara; M van Meurs; J D Laman; E Claassen
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

3.  Best cases from the AFIP: Pulmonary Langerhans cell histiocytosis.

Authors:  Danny L Leatherwood; Darel E Heitkamp; Robert E Emerson
Journal:  Radiographics       Date:  2007 Jan-Feb       Impact factor: 5.333

Review 4.  Langerhans cell histiocytosis: literature review and descriptive analysis of oral manifestations.

Authors:  Cristina Madrigal-Martínez-Pereda; Vanesa Guerrero-Rodríguez; Blanca Guisado-Moya; Cristina Meniz-García
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2009-05-01

5.  Langerhans cell histiocytosis.

Authors:  M de L Chauffaille; R M Valério; C M Diniz; M M Simões; S Enokihara; N Michalany; K V Ferreira; J A Martinez; K M Hassun; A N Atallah; J Kerbauy
Journal:  Sao Paulo Med J       Date:  1998 Jan-Feb       Impact factor: 1.044

6.  Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.

Authors:  Robert Vassallo; Jay H Ryu; Darrell R Schroeder; Paul A Decker; Andrew H Limper
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

7.  Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome.

Authors:  D M Howarth; G S Gilchrist; B P Mullan; G A Wiseman; J H Edmonson; P J Schomberg
Journal:  Cancer       Date:  1999-05-15       Impact factor: 6.860

8.  Langerhans'-cell histiocytosis in adults.

Authors:  I Baumgartner; A von Hochstetter; B Baumert; U Luetolf; F Follath
Journal:  Med Pediatr Oncol       Date:  1997-01

9.  Langerhans cell histiocytosis: presentation and evolution of radiologic findings with clinical correlation.

Authors:  J S Meyer; M P Harty; S Mahboubi; S Heyman; R A Zimmerman; R B Womer; J P Dormans; G J D'Angio
Journal:  Radiographics       Date:  1995-09       Impact factor: 5.333

Review 10.  Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation.

Authors:  Anil K Attili; Ella A Kazerooni; Barry H Gross; Kevin R Flaherty; Jeffrey L Myers; Fernando J Martinez
Journal:  Radiographics       Date:  2008 Sep-Oct       Impact factor: 5.333

  10 in total
  1 in total

1.  Adult onset of multisystem Langerhans cell histiocytosis with skin and lymph node involvement.

Authors:  Izabela Błażewicz; Wojciech Biernat; Anna Kowalczyk; Wioletta Barańska-Rybak; Roman Nowicki; Marta Stawczyk-Macieja; Małgorzata Sokołowska-Wojdyło
Journal:  Postepy Dermatol Alergol       Date:  2015-06-15       Impact factor: 1.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.